Biotech and Pharmaceuticals Medicine

More

  • July 12- Sage Therapeutics Inc said its experimental drug to treat severe postpartum depression met the main goal of alleviating symptoms more than a placebo in a mid-stage study. Postpartum depression, or the "baby blues," impacts some women after childbirth, and can have several manifestations including significant functional impairment, depressed mood...

  • July 11- The U.S. Food and Drug Administration on Monday approved Shire Plc's lifitegrast eye drops for treating signs and symptoms of dry eye disease, allowing the company to bring to market its most important pipeline medicine. Lifitegrast, which will be marketed as Xiidra in the United States, is expected to launch in the third quarter. It treats an eye disease...

  • July 8- Amgen Inc's version of AbbVie Inc's Humira arthritis drug, the world's top-selling medicine, appears similar in potency and safety to the original product, U.S. Food and Drug Administration staff members said on Friday. In two large Amgen studies, the Thousand Oaks, California- based company said it showed similar effectiveness to Humira.

  • July 8- Amgen Inc's version of AbbVie Inc's Humira arthritis drug, the world's top-selling medicine, appears similar in potency and safety to the original product, U.S. Food and Drug Administration staff members said on Friday. In two large Amgen-sponsored studies, the Thousand Oaks, California- based company said it showed similar effectiveness to Humira.

  • July 8- Amgen Inc's biosimilar form of AbbVie Inc's Humira arthritis drug, the world's top-selling medicine, is similarly potent and safe as the original product, according to a preliminary review by staff members of the U.S. Food and Drug Administration. The assessment precedes an all-day meeting on Tuesday of an independent panel of medical advisers who will...

  • Elizabeth Holmes

    U.S. regulators have banned Elizabeth Holmes, the chief executive of Theranos, from owning or operating a laboratory for at least two years.

  • The U.S. Food and Drug Administration halted the trial after a patient died in May and two more died last week, Juno Chief Executive Officer Hans Bishop told reporters on a conference call. Seattle- based Juno said the deaths occurred after the chemotherapy agent fludarabine was added to the trial program. The company said it has proposed to the U.S. Food and Drug...

  • Shares of Juno fell 30 percent to $28.50 in after-hours trading on the Nasdaq after they closed at $40.82. A third trial patient died in May, Juno Chief Executive Officer Hans Bishop said during a conference call. The company said it has proposed to the U.S. Food and Drug Administration that the trial be continued using JCAR015 with just cyclophosphamide as a "...

  • Juno tanks after hours

    CNBC's Meg Tirrell reports the latest on the FDA putting Juno's cancer clinical trial on hold. The "Fast Money" traders weigh in on the biotech sector.

  • Shares of Juno, which closed at $40.82 on Nasdaq, fell 30 percent to $28.50 in after-hours trading. Juno said the FDA asked that the company submit a revised patient consent form, investigator brochure, trial protocol, and a copy of the presentation made to the agency on Wednesday. Juno said it plans to submit the requested information to the FDA this week.

  • CDC sounds Zika alarm

    CNBC's Meg Tirrell reports that the Zika virus is beginning to pick up steam in Puerto Rico, as some 50 women are becoming infected each day.

  • 50 women/day infected with Zika in Puerto Rico: CDC

    CNBC's Meg Tirrell reports on the dire Zika situation in Puerto Rico.

  • WASHINGTON, July 7- The U.S. Centers for Disease Control and Prevention said on Thursday that it is monitoring 320 U.S. pregnant women with laboratory evidence of Zika virus infection, up from 287 women a week earlier. Zika has caused concern throughout the Americas due to an alarming rise in cases of the birth defect microcephaly and other severe fetal brain...

  • The 10 most-expensive prescription drugs

    Prescription drug prices have soared, often exceeding US average annual income. These are the five most expensive. CNBC's Dina Gusovsky reports.

  • July 7- Ablynx's hopes for a potential multibillion-dollar drug were boosted on Thursday by strong clinical trial results in rheumatoid arthritis, vindicating a $175 million bet placed on the product by U.S. pharma group AbbVie in 2013.. Shares in Ablynx jumped 15.1 percent to 13.27 euros by 0948 GMT. "We're getting really stand-out data, which is great, and it is...

  • July 6- Pfizer Inc and German drugmaker Merck KGaA on Wednesday said they had begun a late-stage trial of their immuno-oncology drug avelumab in combination with standard treatment for ovarian cancer. The 950- patient study will enroll patients with advanced ovarian cancer who have not previously been treated for the disease, which is diagnosed annually in...

  • VERDICT IS SECOND TIME DUPONT HAS BEEN FOUND LIABLE FOR DISEASES LINKED TO TEFLON CHEMICAL EXPOSURE.

  • *Accord with Walter Reed Army Institute of Research. PARIS/ LONDON, July 6- French drugmaker Sanofi said on Wednesday it had struck a research and development deal with the U.S. Army to speed up the development of a vaccine against the mosquito-borne Zika virus. The tie-up with the Walter Reed Army Institute of Research in the United States gives Sanofi access to a...

  • A comeback for Google Glass?

    Discussing Google Glass' new role in medicine and how it is helping both doctors and patients with Dr. Peter Chai, University of Massachusetts Medical School.

  • A handful of studies have suggested some ingredients in products get absorbed through the skin.